Intelligent Ultrasound Group PLC Installation of 1000th Simulation System
March 04 2021 - 2:00AM
RNS Non-Regulatory
TIDMIUG
Intelligent Ultrasound Group PLC
04 March 2021
4 March 2021
Intelligent Ultrasound Group plc
(the "Company")
Installation of 1000(th) Simulation System
Point of Care ultrasound scenario trainer installed at Ohio
State University College of Medicine
Intelligent Ultrasound Group plc (AIM: IUG), the ultrasound
artificial intelligence (AI) software and simulation company,
announces that they have recently installed their 1000(th)
ultrasound simulation system, a BodyWorks Eve PoCUS and Covid-19
training simulator, into one of the leading medical institutions in
North America.
The installation, at the Clinical Skills Education and
Assessment Center of the Ohio State University College of Medicine
("OSUCM"), will allow them to expand their education reach beyond
echocardiography and into point of care ultrasound and reduce their
reliance on live models.
Bodyworks(TM) Eve is the Company's ultra-realistic female
patient simulator designed for interactive Point of Care Ultrasound
(PoCUS) scenario training, as well as Covid-19 training for
frontline clinicians.
The addition of the Bodyworks(TM) Eve simulator to OSUCM's
existing HeartWorks(TM) simulation system will allow the medical
school to expand their existing ultrasound training for medical
students to include full chest, abdominal, pelvic, and early OB
(obstetric) critical care.
Ian Whittaker, COO of Intelligent Ultrasound Group plc,
commented: "We are delighted to reach this significant sales
milestone . North America is a key market for our range of
ultrasound training simulators and the Ohio State University
College of Medicine is acknowledged as one of the top teaching
institutions in the US."
For further information, please contact:
Intelligent Ultrasound Group www. intelligentultrasound.com
plc
Stuart Gall, CEO Tel: +44 (0)29 2075 6534
Helen Jones, CFO
Cenkos Securities - Nominated Advisor Tel: +44 (0)20 7397 8900
and Broker
Giles Balleny (Corporate Finance)
Michael Johnson / Julian Morse
(Sales)
Walbrook PR Tel: +44 (0)20 7933 8780 or intelligentultrasound@walbrookpr.com
Anna Dunphy / Paul McManus Mob: +44 (0)7876 741 001 / Mob: +44
(0)7980 541 893
About Intelligent Ultrasound Group
Intelligent Ultrasound (AIM: IUG) develops artificial
intelligence-based clinical image analysis software tools for the
diagnostic medical ultrasound market and hi-fidelity virtual
reality simulators for the ultrasound training market. Based in
Cardiff in the UK and Atlanta in the US, the Group operates two
divisions:
Clinical AI Division
Focusses on developing deep learning-based algorithms to make
ultrasound machines smarter and more accessible. Products in the
market include ScanNav Assist, which uses machine-learning based
algorithms to automatically identify and grade ultrasound images.
GE Healthcare's SonoLyst software on their Voluson SWIFT ultrasound
machine incorporates the ScanNav Assist AI technology and has
received 510(k) clearance from the FDA for sale in the USA.
SonoLyst is the world's first fully integrated AI tool that
recognises the 20 views recommended by the International Society of
Ultrasound in Obstetrics and Gynaecology mid-trimester practice
guidelines for fetal imaging.
Products in development include ScanNav Anatomy PNB, which aims
to simplify ultrasound-guided needling by providing the user with
real-time AI-based anatomy highlighting software for a range of
medical procedures. ScanNav Anatomy has been submitted for CE and
FDA regulatory approval.
Simulation Division
Focusses on hi-fidelity ultrasound education and training
through simulation. Its three main products are the ScanTrainer
OBGYN training simulator, the HeartWorks echocardiography training
simulator and the BodyWorks Eve Point of Care and Emergency
Medicine training simulator. To date over 1,000 simulators have
been sold to over 600 medical institutions around the world.
www.intelligentultrasound.com
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAJJMRTMTMMBAB
(END) Dow Jones Newswires
March 04, 2021 02:00 ET (07:00 GMT)
Intelligent Ultrasound (LSE:MED)
Historical Stock Chart
From Apr 2024 to May 2024
Intelligent Ultrasound (LSE:MED)
Historical Stock Chart
From May 2023 to May 2024